Publications

• Peasland A, Wang LZ, Rowling E, Kyle S, Chen T, Hopkins A, Cliby WA, Sarkaria J, Beale G, Edmondson RJ, Curtin NJ. Identification and evaluation of a potent novel ATR inhibitor, NU6027, in breast and ovarian cancer cell lines. British Journal of Cancer 2011, 105(3), 372-381.
• Peasland A, Matheson E, Hall A, Irving J. Alternative splicing of hMLH1 in childhood acute lymphoblastic leukaemia and characterisation of the variably expressed Δ9/10 isoform as a dominant negative species. Leukemia Research 2010, 34(3), 322-327.
• Squires M, Saxty G, Murray C, Berdini V, Ward G, Miller D, Rich S, Cleasby A, Saalau - Bethell S, Coyle J, Van Montfort R, Madin A, Carr M, OBrien A, GriffithsJones C, Vickerstaff E, Nijjar R, Graham B, Cosme J, Pike A, Lewis J, Batey M, Peasland A, Irving J, Lyons J, Newell D, Thompson N. Development of inhibitors of the fibroblast growth factor receptor (FGFR) kinase using a fragment based approach. In: Proceedings of the American Association for Cancer Research: AACR Annual Meeting 2008. 2008, San Diego, California: American Association for Cancer Research.